Ensuring Provider Education And Readiness For Using A Novel CAR T

Situation:

• Client was launching a novel CAR T-cell therapy in rare hematologic malignancy and company was new to this space
• Client engaged Precision’s support to mount an effective launch by mapping the patient journey in this complex CAR T-cell therapy process, identifying the pain points for access to therapy and addressing the educational needs across stakeholders

Precision partnered with our client to design and implement comprehensive site training and resources to ensure safe use and patient access at launch.